Robert Wood Johnson Medical School Endocrinology, Diabetes, and Metabolism

Topics

• Bone health and osteoporosis research 75
• Diabetes Treatment and Management 49
• Vitamin D Research Studies 46
• Bone health and treatments 40
• Parathyroid Disorders and Treatments 30
• Regulation of Appetite and Obesity 19
• Adipose Tissue and Metabolism 15
• Metabolism, Diabetes, and Cancer 14
• Diabetes Management and Research 12
• Pituitary Gland Disorders and Treatments 12
• Thyroid Disorders and Treatments 12
• Diabetes and associated disorders 10

Most cited

1. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.

   Nature medicine · 2022 · 758 citations · Afshin Salsali

2. Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity.

   Cell metabolism · 2025 · 84 citations · Christoph Buettner

3. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.

   European heart journal · 2023 · 192 citations · Afshin Salsali

4. GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.

   Journal of clinical & translational endocrinology · 2024 · 68 citations · Julie Zaidan

5. The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF).

   Cardiovascular diabetology · 2025 · 46 citations · Karolina Janiec

6. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.

   European heart journal · 2021 · 182 citations ·